Curaleaf Holdings announced the launch of Plant Precision, a collection of edibles and a topical gel designed to target specific wellness categories.
According to a Curaleaf / Harris Poll survey, 69% of Americans say they would be more likely to use cannabis as a health solution if it came in small, controlled doses. Curaleaf recognized this need and created an approachable line for the newer consumer featuring gummy edibles offering low, customizable doses of THC and high doses of non-psychoactive therapeutic minor cannabinoids like CBD, CBG, CBN and THCV, and an absorbent THC topical gel.
Plant Precision allows consumers to explore a range of potentially therapeutic destinations such as:
- Balance: an apple-flavored gummy containing 2.5mg THC and 10mg CBD
- Slumber: a cherry-flavored gummy containing 2.5mg THC and 10mg CBN
- Soothe: a pineapple-flavored gummy containing 2.5mg THC and 10mg CBG
- Boost: a lemon-flavored gummy containing 2.5mg THC and 10mg THCV
- Relieve: a high absorbing topical gel with 100% THC designed to rapidly ease tension with a 30–45-minute onset time
The minor cannabinoids featured in Plant Precision gummies are non-psychoactive and do not create the euphoric feeling like THC does, but instead interact differently with the human receptor systems yielding different biological effects. The Plant Precision gummies utilize liposomal encapsulation, a technology which envelopes the cannabinoid molecules, to help maximize every milligram. Moreover, each of the Plant Precision Gummy lines contain formulated blends of terpenes that contribute to the entourage effect, which occurs when minor cannabinoids interact with THC to create a unique effect with potential therapeutic benefits.
The Plant Precision Topical Gel was engineered using hydro-alcoholic technology to facilitate the delivery of cannabinoids through the skin and contains 650mg of total THC – higher than nearly all marketed THC topicals.
"With Plant Precision we wanted to create a simplified way people can incorporate cannabis into their daily health and wellness routines," said Matt Darin, CEO of Curaleaf. "These products empower people to explore cannabis beyond THC and CBD and offers more customizable solutions on how the plant can best serve a consumer's personalized needs."